| Ημερομηνία | barcode | code | περιεχομενο | τιμή παραγωγός | χονδρική | λιανική |
|---|---|---|---|---|---|---|
| 05/2018 | 2800856402014 | 85640201 | BETNOVATE CREAM 0,1% (W/W) TUBX25G | 1.21 | 1.27 | 1.75 |
| 05/2018 | 2800856402021 | 85640202 | BETNOVATE CREAM 0,1% (W/W) TUBX30G | 1.61 | 1.69 | 2.33 |
| 05/2018 | 2800856403011 | 85640301 | BETNOVATE CUT.SOL 0,1% MG/ML FLX50ML SCALP APPLIC | 3.25 | 3.41 | 4.70 |
Used topically as an antiinflammatory in the treatment of steroid-responsive dermatoses
Hydrocortamate binds to the cytosolic glucocorticoid receptor. After binding the receptor the newly formed receptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing the increase in expression of specific target genes. The anti-inflammatory actions of corticosteroids are thought to involve lipocortins, phospholipase A2 inhibitory proteins which, through inhibition arachidonic acid, control the biosynthesis of prostaglandins and leukotrienes. The immune system is suppressed by corticosteroids due to a decrease in the function of the lymphatic system, a reduction in immunoglobulin and complement concentrations, the precipitation of lymphocytopenia, and interference with antigen-antibody binding.
Side effects include burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, miliaria.